Symbols / IVF $0.77 -3.46%
IVF Chart
About
INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services; INVOcell Device; and Therapeutics segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. It also operates fertility clinics, including INVO Centers. In addition, the company develops NY-303, a GPC3 x NKp46 bifunctional antibody that is in Phase i/ii a monotherapy trial for the treatment of hepatocellular carcinoma; and NY-500, an AI-optimized bifunctional antibody. The company was formerly known as NAYA Biosciences, Inc. and changed its name to INVO Fertility, Inc. in April 2025. INVO Fertility, Inc. was founded in 2007 and is based in Sarasota, Florida.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Devices | Market Cap | 5.38M |
| Enterprise Value | 14.22M | Income | -11.22M | Sales | 6.94M |
| Book/sh | -4.47 | Cash/sh | 0.19 | Dividend Yield | — |
| Payout | 0.00% | Employees | 33 | IPO | — |
| P/E | — | Forward P/E | -0.17 | PEG | — |
| P/S | 0.77 | P/B | -0.17 | P/C | — |
| EV/EBITDA | -2.00 | EV/Sales | 2.05 | Quick Ratio | 0.07 |
| Current Ratio | 0.12 | Debt/Eq | 72.39 | LT Debt/Eq | — |
| EPS (ttm) | -294.88 | EPS next Y | -4.64 | EPS Growth | — |
| Revenue Growth | 22.60% | Earnings | 2025-04-30 09:00 | ROA | -48.36% |
| ROE | — | ROIC | — | Gross Margin | 39.17% |
| Oper. Margin | -93.08% | Profit Margin | 0.00% | Shs Outstand | 6.96M |
| Shs Float | 1.73M | Short Float | 7.66% | Short Ratio | 0.14 |
| Short Interest | — | 52W High | 76.80 | 52W Low | 0.71 |
| Beta | — | Avg Volume | 7.39M | Volume | 155.84K |
| Target Price | $4.00 | Recom | None | Prev Close | $0.80 |
| Price | $0.77 | Change | -3.46% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
News
RSS: Latest IVF news- IVF Stock Price, Quote & Chart | INVO FERTILITY INC (NASDAQ:IVF) - ChartMill Fri, 13 Mar 2026 07
- New IVF tech lets Wisconsin patients watch embryos grow on video - Stock Titan hu, 05 Mar 2026 08
- symbol__ Stock Quote Price and Forecast - CNN ue, 06 May 2025 19
- A Little-Known Fertility Stock Soared 350% — Here’s What Traders Are Watching - Stocktwits ue, 20 Jan 2026 08
- Why Is INVO Fertility Stock (IVF) Up Today? - TipRanks ue, 20 Jan 2026 08
- INVO Fertility stock soars after planned acquisition of Indiana clinic - Investing.com Fri, 28 Nov 2025 08
- INVO Fertility, Inc. Announces 1-for-8 Reverse Stock Split Effective November 28, 2025 - Quiver Quantitative ue, 25 Nov 2025 08
- Why INVO Fertility (IVF) Stock Is Trending Overnight - Benzinga ue, 20 Jan 2026 08
- Swan Defence stock hits lower circuit after board approves 5% promoter stake sale via OFS route; check floor price - Upstox Wed, 18 Mar 2026 04
- IVF (INVO Fertility, NASDAQ) up 191.73% pre-market Jan 21 2026: Most active with heavy volume - Meyka Wed, 21 Jan 2026 08
- Top-rated Indiana fertility clinic sold for $760K to INVO Fertility - Stock Titan hu, 19 Feb 2026 08
- Retail Investors Push INVO Fertility (IVF) Stock Higher; Here’s What’s Ahead - TipRanks ue, 20 Jan 2026 08
- INVO Fertility announces 1-for-8 reverse stock split effective Nov 28 - Investing.com ue, 25 Nov 2025 08
- $IVF stock is up 61% today. Here's what we see in our data. - Quiver Quantitative ue, 27 Jan 2026 08
- Indiana fertility clinic serving thousands of patients is getting new owner - Stock Titan Wed, 17 Dec 2025 08
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 4 | 6 | — | Sale at price 1.52 per share. | SZOT MATTHEW K | Director | — | 2025-12-03 00:00:00 | D |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | -1.14K | -53.23K | -727.23 | 42.01K |
| TaxRateForCalcs | 0.00 | 0.21 | 0.21 | 0.27 |
| NormalizedEBITDA | -6.69M | -6.63M | -10.75M | -5.37M |
| TotalUnusualItems | -457.60K | -253.49K | -3.46K | 155.59K |
| TotalUnusualItemsExcludingGoodwill | -457.60K | -253.49K | -3.46K | 155.59K |
| NetIncomeFromContinuingOperationNetMinorityInterest | -9.10M | -8.03M | -10.89M | -6.65M |
| ReconciledDepreciation | 919.60K | 200.89K | 77.30K | 166.08K |
| ReconciledCostOfRevenue | 3.66M | 1.93M | 850.77K | 145.05K |
| EBITDA | -7.14M | -6.88M | -10.75M | -5.22M |
| EBIT | -8.06M | -7.08M | -10.83M | -5.38M |
| NetInterestIncome | -1.06M | -925.91K | -59.14K | -1.26M |
| InterestExpense | 1.06M | 925.91K | 59.45K | 1.27M |
| InterestIncome | 0.00 | 308.00 | 3.66K | |
| NormalizedIncome | -8.64M | -7.83M | -10.89M | -6.77M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -9.10M | -8.03M | -10.89M | -6.65M |
| TotalExpenses | 14.15M | 9.79M | 11.45M | 9.38M |
| TotalOperatingIncomeAsReported | -8.13M | -6.77M | -10.63M | -5.22M |
| DilutedAverageShares | 12.90K | 4.97K | 2.10K | 1.84K |
| BasicAverageShares | 12.90K | 4.97K | 2.10K | 1.84K |
| DilutedEPS | -724.56 | -1.62K | -5.18K | -3.63K |
| BasicEPS | -724.56 | -1.62K | -5.18K | -3.63K |
| DilutedNIAvailtoComStockholders | -9.35M | -8.03M | -10.89M | -6.65M |
| NetIncomeCommonStockholders | -9.35M | -8.03M | -10.89M | -6.65M |
| OtherunderPreferredStockDividend | 250.63K | 0.00 | ||
| NetIncome | -9.10M | -8.03M | -10.89M | -6.65M |
| NetIncomeIncludingNoncontrollingInterests | -9.10M | -8.03M | -10.89M | -6.65M |
| NetIncomeContinuousOperations | -9.10M | -8.03M | -10.89M | -6.65M |
| TaxProvision | -22.91K | 27.79K | 2.87K | 4.76K |
| PretaxIncome | -9.12M | -8.01M | -10.89M | -6.65M |
| OtherIncomeExpense | -448.56K | -313.76K | -204.02K | -171.95K |
| SpecialIncomeCharges | -457.60K | -253.07K | 0.00 | 159.13K |
| GainOnSaleOfPPE | -511.66K | 0.00 | ||
| OtherSpecialCharges | -54.06K | 163.28K | -159.13K | |
| WriteOff | 0.00 | 89.79K | 0.00 | |
| EarningsFromEquityInterest | 9.04K | -60.27K | -200.56K | -327.54K |
| GainOnSaleOfSecurity | -420.00 | -3.46K | -3.53K | |
| NetNonOperatingInterestIncomeExpense | -1.06M | -925.91K | -59.14K | -1.26M |
| InterestExpenseNonOperating | 1.06M | 925.91K | 59.45K | 1.27M |
| InterestIncomeNonOperating | 0.00 | 308.00 | 3.66K | |
| OperatingIncome | -7.61M | -6.77M | -10.63M | -5.22M |
| OperatingExpense | 10.49M | 7.85M | 10.60M | 9.23M |
| DepreciationAmortizationDepletionIncomeStatement | 919.60K | 200.89K | 77.30K | |
| DepreciationAndAmortizationInIncomeStatement | 919.60K | 200.89K | 77.30K | |
| ResearchAndDevelopment | 489.66K | 165.94K | 544.04K | 216.43K |
| SellingGeneralAndAdministration | 9.08M | 7.49M | 9.98M | 9.02M |
| GrossProfit | 2.87M | 1.09M | -28.57K | 4.02M |
| CostOfRevenue | 3.66M | 1.93M | 850.77K | 145.05K |
| TotalRevenue | 6.53M | 3.02M | 822.20K | 4.16M |
| OperatingRevenue | 6.53M | 3.02M | 822.20K | 4.16M |
| Line Item | 2023-12-31 | |||
|---|---|---|---|---|
| TreasurySharesNumber | 0.00 | |||
| OrdinarySharesNumber | 15.54K | 8.65K | 2.11K | 2.07K |
| ShareIssued | 15.54K | 8.65K | 2.11K | 2.07K |
| NetDebt | 6.73M | 2.53M | 672.51K | |
| TotalDebt | 9.90M | 6.30M | 2.27M | 2.12M |
| TangibleBookValue | -59.27M | -15.08M | -977.61K | 7.18M |
| InvestedCapital | -10.16M | -2.34M | -214.97K | 7.31M |
| WorkingCapital | -16.61M | -6.74M | -2.72M | 5.05M |
| NetTangibleAssets | -28.89M | -9.08M | -977.61K | 7.18M |
| CapitalLeaseObligations | 2.43M | 3.54M | 1.51M | 2.12M |
| CommonStockEquity | -17.63M | -5.11M | -977.61K | 7.31M |
| PreferredStockEquity | 30.38M | 6.00M | ||
| TotalCapitalization | 13.88M | 2.15M | -977.61K | 7.31M |
| TotalEquityGrossMinorityInterest | 12.75M | 892.60K | -977.61K | 7.31M |
| StockholdersEquity | 12.75M | 892.60K | -977.61K | 7.31M |
| RetainedEarnings | -67.16M | -57.82M | -49.78M | -38.89M |
| AdditionalPaidInCapital | 49.54M | 52.71M | 48.81M | 46.20M |
| CapitalStock | 30.38M | 6.00M | 61.00 | 1.19K |
| CommonStock | 37.00 | 20.00 | 61.00 | 1.19K |
| PreferredStock | 30.38M | 6.00M | 0.00 | |
| TotalLiabilitiesNetMinorityInterest | 33.70M | 17.61M | 4.69M | 3.16M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 15.78M | 9.61M | 1.35M | 1.90M |
| OtherNonCurrentLiabilities | 229.00 | |||
| PreferredSecuritiesOutsideStockEquity | 7.46M | 0.00 | ||
| TradeandOtherPayablesNonCurrent | 5.00M | 5.00M | 0.00 | |
| NonCurrentDeferredLiabilities | 0.00 | 1.95K | 1.14K | |
| NonCurrentDeferredRevenue | 0.00 | |||
| NonCurrentDeferredTaxesLiabilities | 0.00 | 1.95K | 1.14K | |
| LongTermDebtAndCapitalLeaseObligation | 3.32M | 4.61M | 1.35M | 1.90M |
| LongTermCapitalLeaseObligation | 2.19M | 3.36M | 1.35M | 1.90M |
| LongTermDebt | 1.13M | 1.25M | ||
| CurrentLiabilities | 17.93M | 8.00M | 3.34M | 1.25M |
| OtherCurrentLiabilities | 410.00K | 350.00K | ||
| CurrentDeferredLiabilities | 602.36K | 408.77K | 119.88K | 5.90K |
| CurrentDeferredRevenue | 602.36K | 408.77K | 119.88K | 5.90K |
| CurrentDebtAndCapitalLeaseObligation | 6.58M | 1.69M | 922.83K | 221.99K |
| CurrentCapitalLeaseObligation | 239.12K | 181.57K | 160.19K | 221.99K |
| CurrentDebt | 6.34M | 1.51M | 762.64K | |
| OtherCurrentBorrowings | 5.46M | 629.92K | 100.00K | |
| CurrentNotesPayable | 880.00K | 880.00K | 662.64K | 0.00 |
| PensionandOtherPostRetirementBenefitPlansCurrent | 2.12M | 722.25K | 946.26K | 581.69K |
| PayablesAndAccruedExpenses | 8.21M | 4.83M | 1.35M | 443.42K |
| Payables | 8.21M | 4.83M | 1.35M | 443.42K |
| OtherPayable | 2.50M | 2.50M | ||
| TotalTaxPayable | 0.00 | |||
| IncomeTaxPayable | 0.00 | |||
| AccountsPayable | 5.71M | 2.33M | 1.35M | 443.42K |
| TotalAssets | 46.45M | 18.51M | 3.71M | 10.47M |
| TotalNonCurrentAssets | 45.13M | 17.25M | 3.09M | 4.16M |
| InvestmentsAndAdvances | 740.76K | 3.09M | 1.24M | 1.49M |
| LongTermEquityInvestment | 740.76K | 3.09M | 1.24M | 1.49M |
| InvestmentsinJointVenturesatCost | 740.76K | 916.25K | 1.24M | 1.49M |
| InvestmentsinSubsidiariesatCost | 0.00 | 2.17M | 0.00 | |
| GoodwillAndOtherIntangibleAssets | 41.64M | 9.97M | 0.00 | 132.09K |
| OtherIntangibleAssets | 18.10M | 4.09M | 132.09K | |
| Goodwill | 23.54M | 5.88M | 0.00 | |
| NetPPE | 2.75M | 4.19M | 1.85M | 2.54M |
| AccumulatedDepreciation | -335.69K | -233.59K | -153.27K | -78.21K |
| GrossPPE | 3.09M | 4.42M | 2.00M | 2.62M |
| Leases | 96.82K | 538.15K | 96.82K | 96.82K |
| OtherProperties | 2.90M | 3.80M | 1.83M | 2.44M |
| MachineryFurnitureEquipment | 89.90K | 85.40K | 77.60K | 74.89K |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 1.32M | 1.26M | 621.09K | 6.31M |
| OtherCurrentAssets | 182.29K | 622.29K | 190.20K | 282.75K |
| PrepaidAssets | 282.75K | |||
| Inventory | 219.76K | 264.51K | 263.60K | 287.77K |
| FinishedGoods | 166.23K | 211.03K | 194.88K | 220.17K |
| WorkInProcess | 0.00 | |||
| RawMaterials | 53.54K | 53.48K | 68.72K | 67.61K |
| Receivables | 174.88K | 140.55K | 77.15K | 50.47K |
| AccountsReceivable | 174.88K | 140.55K | 77.15K | 50.47K |
| CashCashEquivalentsAndShortTermInvestments | 741.40K | 232.42K | 90.14K | 5.68M |
| CashAndCashEquivalents | 741.40K | 232.42K | 90.14K | 5.68M |
| CashFinancial | 741.40K | 232.42K | 90.14K | 5.68M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -3.16M | -5.20M | -6.62M | -6.48M |
| RepaymentOfDebt | -934.42K | -1.50M | 0.00 | -250.00K |
| IssuanceOfDebt | 1.34M | 3.16M | 800.00K | 0.00 |
| IssuanceOfCapitalStock | 1.81M | 5.70M | 289.80K | 3.65M |
| CapitalExpenditure | -183.70K | -444.72K | -12.73K | -454.65K |
| InterestPaidSupplementalData | 214.74K | 9.64K | 0.00 | 52.60K |
| IncomeTaxPaidSupplementalData | 0.00 | 0.00 | 800.00 | 3.31K |
| EndCashPosition | 741.40K | 232.42K | 90.14K | 5.68M |
| BeginningCashPosition | 232.42K | 90.14K | 5.68M | 10.10M |
| ChangesInCash | 508.97K | 142.29K | -5.59M | -4.41M |
| FinancingCashFlow | 3.12M | 7.39M | 1.09M | 3.77M |
| CashFlowFromContinuingFinancingActivities | 3.12M | 7.39M | 1.09M | 3.77M |
| ProceedsFromStockOptionExercised | 900.61K | 25.43K | 0.00 | 369.84K |
| NetPreferredStockIssuance | 1.64M | 0.00 | ||
| PreferredStockIssuance | 1.64M | 0.00 | ||
| NetCommonStockIssuance | 165.13K | 5.70M | 289.80K | 3.65M |
| CommonStockIssuance | 165.13K | 5.70M | 289.80K | 3.65M |
| NetIssuancePaymentsOfDebt | 409.83K | 1.66M | 800.00K | -250.00K |
| NetShortTermDebtIssuance | 0.00 | 100.00K | 800.00K | -250.00K |
| ShortTermDebtPayments | 0.00 | -250.00K | ||
| ShortTermDebtIssuance | 0.00 | 100.00K | 800.00K | 0.00 |
| NetLongTermDebtIssuance | 409.83K | 1.66M | 800.00K | -250.00K |
| LongTermDebtPayments | -934.42K | -1.50M | 0.00 | -250.00K |
| LongTermDebtIssuance | 1.34M | 3.16M | 800.00K | 0.00 |
| InvestingCashFlow | 363.89K | -2.49M | -81.22K | -2.15M |
| CashFlowFromContinuingInvestingActivities | 363.89K | -2.49M | -81.22K | -2.15M |
| NetBusinessPurchaseAndSale | 472.01K | -2.05M | -68.49K | -1.70M |
| SaleOfBusiness | 472.01K | 0.00 | ||
| PurchaseOfBusiness | 0.00 | -2.05M | -68.49K | -1.70M |
| NetIntangiblesPurchaseAndSale | 0.00 | -1.94K | -38.94K | |
| PurchaseOfIntangibles | 0.00 | -1.94K | -38.94K | |
| NetPPEPurchaseAndSale | -108.11K | -444.72K | -10.79K | -415.71K |
| SaleOfPPE | 75.59K | 0.00 | ||
| PurchaseOfPPE | -183.70K | -444.72K | -10.79K | -415.71K |
| OperatingCashFlow | -2.97M | -4.76M | -6.60M | -6.03M |
| CashFlowFromContinuingOperatingActivities | -2.97M | -4.76M | -6.60M | -6.03M |
| ChangeInWorkingCapital | 1.86M | 471.70K | 1.48M | -3.61M |
| ChangeInOtherWorkingCapital | 193.59K | 286.94K | 114.79K | -3.51M |
| ChangeInOtherCurrentLiabilities | 25.87K | -141.38K | 7.03K | -53.85K |
| ChangeInOtherCurrentAssets | 4.53K | 0.00 | ||
| ChangeInPayablesAndAccruedExpense | 1.79M | 822.53K | 1.27M | 135.02K |
| ChangeInAccruedExpense | 441.44K | -102.15K | 366.13K | 20.92K |
| ChangeInInterestPayable | 166.77K | 121.86K | 1.56K | 20.92K |
| ChangeInPayable | 1.35M | 924.68K | 904.06K | 114.10K |
| ChangeInAccountPayable | 1.35M | 924.68K | 904.06K | 114.50K |
| ChangeInTaxPayable | 0.00 | -392.00 | ||
| ChangeInIncomeTaxPayable | 0.00 | -392.00 | ||
| ChangeInPrepaidAssets | -163.76K | -432.09K | 92.55K | -124.81K |
| ChangeInInventory | 44.74K | -905.00 | 24.17K | -22.40K |
| ChangeInReceivables | -34.33K | -63.40K | -26.68K | -28.77K |
| ChangesInAccountReceivables | -34.33K | -63.40K | -26.68K | -28.77K |
| OtherNonCashItems | 1.21M | 900.13K | 172.64K | 1.19M |
| StockBasedCompensation | 1.59M | 1.39M | 2.22M | 2.71M |
| AssetImpairmentCharge | 0.00 | 89.79K | 132.23K | 0.00 |
| DepreciationAmortizationDepletion | 919.60K | 200.89K | 77.30K | 166.08K |
| DepreciationAndAmortization | 919.60K | 200.89K | 77.30K | 166.08K |
| Depreciation | 306.32K | 166.08K | ||
| OperatingGainsLosses | 543.11K | 223.55K | 200.56K | 168.42K |
| EarningsLossesFromEquityInvestments | -9.04K | 60.27K | 200.56K | 327.54K |
| GainLossOnSaleOfPPE | 511.66K | 0.00 | ||
| NetIncomeFromContinuingOperations | -9.10M | -8.03M | -10.89M | -6.65M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for IVF
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|